Mutations in the Hepatocyte Nuclear Factor-1alpha Gene in Caucasian Families Originally Classified As Having Type I Diabetes
Overview
Affiliations
Mutations in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene are the cause of maturity-onset diabetes of the young type 3 (MODY3), which is characterised by a severe impairment of insulin secretion and an early onset of the disease. Also at onset of diabetes some MODY patients show similar clinical symptoms and signs as patients with Type I (insulin-dependent) diabetes mellitus. The objective of this study was to estimate the prevalence of MODY3 patients misclassified as Type I diabetic patients. From a large population-based sample of unrelated Danish Caucasian Type I diabetic patients with an affected first degree relative, 39 patients (6.7%) who did not carry any high-risk HLA-haplotypes, i.e. DR3 or DR4 or both were examined by single-strand conformational polymorphism scanning and direct sequencing of the coding region and the minimal promoter of the HNF-1alpha gene. Four of the 39 Type I diabetic patients (10%) were identified as carrying mutations in the HNF-1alpha gene. One patient carried a missense mutation (Glu48Lys) in exon 1, two patients carried a missense mutation (Cys241Gly) in exon 4 and one patient carried a frameshift mutation (Pro291fsdelA) in exon 4. The mutations were all identified in heterozygous form, segregated with diabetes, and were not identified in 84 unrelated, healthy subjects. Furthermore, family history in three of the four families showed diabetes in four consecutive generations, suggestive of an autosomal dominant inheritance. In conclusion, about 10% of Danish diabetic patients without a high-risk HLA-haplotype, originally classified as having Type I diabetes could have diabetes caused by mutations in the HNF-1alpha gene. Clinical awareness of family history of diabetes and mode of inheritance might help to identify and reclassify these diabetic subjects as MODY3 patients.
A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms.
Welsch S, Harvengt A, Gallo P, Martin M, Beckers D, Mouraux T Diabetes Metab J. 2024; 48(5):949-959.
PMID: 38523249 PMC: 11449816. DOI: 10.4093/dmj.2023.0166.
Greeley S, Polak M, Njolstad P, Barbetti F, Williams R, Castano L Pediatr Diabetes. 2022; 23(8):1188-1211.
PMID: 36537518 PMC: 10107883. DOI: 10.1111/pedi.13426.
Haque E, Teeli A, Winiarczyk D, Taguchi M, Sakuraba S, Kono H Genes (Basel). 2022; 13(3).
PMID: 35327967 PMC: 8949677. DOI: 10.3390/genes13030413.
HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.
Li L, Jiang B, Sun L Front Endocrinol (Lausanne). 2022; 13:829565.
PMID: 35299962 PMC: 8921476. DOI: 10.3389/fendo.2022.829565.
Passanisi S, Salzano G, Bombaci B, Lombardo F Diabetol Metab Syndr. 2021; 13(1):96.
PMID: 34496959 PMC: 8424812. DOI: 10.1186/s13098-021-00716-6.